Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT04925089
Recruiting
Localized Leiomyosarcoma Biomarker Protocol
Not applicable · United States · 3 sites
Registry update: 2 Jul 2026
NCT05019703
Recruiting
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
Phase 2 · United States · 2 sites
Registry update: 6 Oct 2026
NCT05755113
Recruiting
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Phase 2 · United States · 1 site
Registry update: 12 Mar 2026
NCT05328258
Recruiting
Use of GnRHa During Chemotherapy for Fertility Protection
Phase 3 · Sweden · 11 sites
Registry update: 27 Oct 2023
NCT06760221
Recruiting
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
Not applicable · China · 1 site
Registry update: 6 Jan 2025
NCT05743426
Recruiting
Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Not applicable · United States · 1 site
Registry update: 30 Mar 2026
NCT05210374
Recruiting
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Phase 1 · United States · 1 site
Registry update: 6 Aug 2026
NCT05857969
Recruiting
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · United States · 1 site
Registry update: 26 Aug 2026
NCT06062927
Recruiting
Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma
Not applicable · China · 1 site
Registry update: 2 Oct 2023
NCT05492682
Recruiting
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Phase 1 · Germany, Italy · 9 sites
Registry update: 12 May 2026
Conflicting statuses (not updated in the registry for 5 months)
NCT06132503
Recruiting
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Phase 1 · United States · 1 site
Registry update: 4 May 2026
NCT05779670
Recruiting
Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
Not applicable · Italy · 1 site
Registry update: 3 Feb 2026
NCT05697874
Recruiting
International Rare Brain Tumor Registry
Not applicable · Brazil, Colombia, Israel, United States · 13 sites
Registry update: 7 Aug 2026
NCT05653388
Recruiting
Metastatic Leiomyosarcoma Biomarker Protocol
Not applicable · Australia, United States · 11 sites
Registry update: 24 Jun 2026
NCT05646316
Recruiting
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Phase 3 · South Korea, United States · 60 sites
Registry update: 6 Nov 2026
NCT05634369
Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Phase 1/2 · United States · 22 sites
Registry update: 28 Jan 2026
NCT05620693
Recruiting
Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
Not applicable · China · 1 site
Registry update: 22 Nov 2022
NCT05607095
Recruiting
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
Phase 1 · United States · 2 sites
Registry update: 15 Sept 2026
NCT05952310
Recruiting
Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas
Not applicable · Spain · 1 site
Registry update: 21 Jul 2023
2024-513431-25-00
Recruiting
Clinical trial of infusion of activated NK cells for the treatment of children, adolescents and young adults with sarcomas.
Phase 1/2 · Spain · 1 site
Registry update: 18 Apr 2024

Ordered by registry start date. Freshness and sponsorship never change the order.